C-NUCLEOSIDES, C-NUCLEOTIDES AND THEIR ANALOGS, EQUIVALENTS AND PRODRUGS THEREOF FOR ECTONUCLEOTIDASE INHIBITION

The invention provides novel heterocyclic C-nucleosides, C-nucleotides and their analogues, equivalents, and prodrug thereof. The compounds, compositions, and methods provided of the invention, by themselves or in combination with other therapies are useful for the treatment of a disease, disorder o...

Full description

Saved in:
Bibliographic Details
Main Authors OH, Su-Sung, KWON, A Ra, BYEON, Seong Rim, CHOI, Young Il
Format Patent
LanguageEnglish
French
Published 04.03.2021
Subjects
CHEMISTRY
DERIVATIVES THEREOF
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SUGARS
Online AccessGet full text

Cover

More Information
Summary:The invention provides novel heterocyclic C-nucleosides, C-nucleotides and their analogues, equivalents, and prodrug thereof. The compounds, compositions, and methods provided of the invention, by themselves or in combination with other therapies are useful for the treatment of a disease, disorder or condition related to CD73 (ecto-5'-nucleotidase) enzyme. L'invention concerne de nouveaux C-nucléosides, C-nucléotides hétérocycliques et leurs analogues, équivalents et promédicaments de ceux-ci. Les composés, les compositions et les procédés selon l'invention, seuls ou en combinaison avec d'autres thérapies, sont utiles pour le traitement d'une maladie, d'un trouble ou d'un état pathologique lié à l'enzyme (ecto-5'-nucléotidase) CD73.
Bibliography:Application Number: WO2020KR11268